[Oral administration of OK-432 (picibanil). (8th report) clinical application: its immunomodulatory effects on the patients with gastrointestinal cancers].
Y Nio, Takashi Tobe, Shin‐ichiro Imai(Washington University in St. Louis), T Tsuchitani, Hiroshi Morimoto, Chia‐Cheng Tseng, Takahiro Shiraishi, M Tsubono, Kippei Ohgaki
PubMed
August 20, 1989
Cited by 1
Related Papers
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
|Nature|2000|3.5k
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
|Cell|2001|2.7k
NAD+ and sirtuins in aging and disease
|Trends in Cell Biology|2014|1.4k